Healthcare professional reported a patient was injected with juvéderm® voluma¿ xc in the lower eyelid and lateral cheek junction in the zygomatic region.Approximately eight months after the injection, patient presented to the office for evaluation of a painless, right lower eyelid mass that was present for 6 months.Examination revealed a "right lower eyelid, palpable, painless, well-circumscribed, mobile mass that appeared posterior to the orbital septum.[their] visual acuity was 20/20 in the right eye with normal pupillary function, full extraocular motility, and unremarkable hertel exophthalmometry and optic nerve function." patient underwent a successful anterior orbitotomy through a transconjunctival incision that revealed a cystic encapsulated lesion.The lesion was sent for histologic analysis, which showed acellular grey-blue material surrounded by multinucleate foreign body giant cells consistent with hyaluronic acid-based filler.It was reported the "filler had migrated across the orbital septum".The patient was seen at two-week, six-week, and three-month postop appointments without any complications and full resolution of symptoms.
|
The filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.Article citation: dryden, stephen et al."a case of orbital granuloma secondary to dermal filler injection", cureus, 13(12), doi: 10.7759/cureus.20606.Further information regarding event, product, and patient details has been requested from corresponding author.No additional information is available at this time.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.This is a known potential adverse event addressed in the product labeling.
|